Abstract:By using unsymmetrical pyrazine- and pyrimidine-modulated oligo- alpha-pyridylamine ligand N-(4-methylpyrimidin-2-yl)pyrazin-2-amine (Hmpmpza) ( 1 ), 1D copper(II) coordination polymer {[Cu(mpmpza)(CH 3 COO)] (CH 3 OH)(H 2 O)} n ( 2 ) and mononuclear copper(II) complex [Cu(Hmpmpza)(NO 3 ) 2 ] ( 3 ) were first successfully synthesized and structurally characterized. In complex ( 2 ), Cu(II) is six-coordinated in an elongated octahedral geometry. The Hmpmpza molecule coordinates with the Cu(II) as a tridentate ligand, in which the pyrimidine and amine group nitrogen atoms link the coordination units to an infinite 1-D chain polymer. Extensive hydrogen bonds between amino groups, acetate anions, methanol, and water molecules are observed in 2 , resulting in a 3D network of the 2 . Complex 2 provides the first example of the complex with a modulated Hdpa ligand, in which nitrogen atoms both of the pyrazine and pyrimidine cycles participated in the coordination with the metal center. There are two crystallographically independent molecules in a mononuclear complex 3 and the Cu(II) atom is sixcoordinated in an elongated octahedral geometry. Hmpmpza in complex 3 coordinates to the Cu(II) in an antianti conformation as a bidentate ligand. The hydrogen bonds between amino groups and coordinated nitrate anions in complex 3 , link its molecules to a 1-D chain structure. However, no hydrogen bonding linkage between the 1-D chains is observed. The temperature dependence magnetic susceptibility measurement for complex 2 described by the Bonner -Fischer approximation shows a weak antiferromagnetic coupling between Cu(II) ions. The best fitting results were obtained with parameters g = 2.141, J = -0.73 cm -1 and R = 4.85 x 10 -6 . The molecular dynamics (MD) simulations of the 2- hAChE, 3-hAChE, 2-hBChE, and 3-hBChE complexes offer comprehensive insights into the stability and dynamic behavior of ligand-protein interactions. These findings contribute to a detailed understanding of the specific dynamics governing the stability of acetylcholinesterase and butyrylcholinesterase complexes.

New Polymorphs of Huperzine A: Preparation, Structures, and Physicochemical Properties of Anhydrous Crystal Forms

Two New Polymorphs of Huperzine A Obtained from Different Dehydration Processes of One Monohydrate

Polymorphism and Isomorphism of Huperzine A Solvates: Structure, Properties and Form Transformation

Synthesis, Crystal Structures, Fluorescence and Xanthine Oxidase Inhibitory Activity of Pyrazole-Based 1,3,4-Oxadiazole Derivatives

Synthesis And Characterization Of 5-Hydroxy-2-(2-Phenylethyl)Chromone (5-Hpec) And Its Analogues As Non-Nitrogenous 5-Ht2b Ligands

Polymorphs and pharmacokinetics of an antipsychotic drug candidate

A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies

Synthesis of 1,3‐Disubtitituted Tetrahydropyrimidinium Salts and Determination of Their Biological Properties and Molecular Docking

( S )- N -Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1 H )-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity.

Huperzine A As Potential Treatment Of Alzheimer'S Disease: An Assessment On Chemistry, Pharmacology, And Clinical Studies

Synthesis, computational docking and molecular dynamics studies of a new class of spiroquinoxalinopyrrolidine embedded chromanone hybrids as potent anti-cholinesterase agents

Molecular modeling of multi-target analogs of huperzine A and applications in Alzheimer's disease

Total Syntheses of (−)‐huperzine Q and (+)‐lycopladines B and C

Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.

Characteristics of Huperzine A Structure in Huperzine A -Acetylcholinesterase Complex-A Quantum Chemistry Study

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine

Synthesis, Characterization, Crystal Structure, Molecular Dynamics Simulations, MM-GBSA Analysis, and Bioactivity Studies of Pyrazine- and Pyrimidine-Modulated Unsymmetrical Dipyridylamide Complexes

Design, synthesis and anti-Alzheimer's disease activity evaluation of C-3 arylated huperzine A derivatives

Two Cocrystal Polymorphs of Palmatine Chloride with Racemic Hesperetin

Design, synthesis, biological evaluation of a new tricyclicthiazolopy‐rimidinone derivatives as acetylcholinesterase inhibitors

Novel 16-substituted bifunctional derivatives of huperzine B: multifunctional cholinesterase inhibitors